Codes, I believe most of the big guys have reviewed what they can get around or not for a long time...they know, probably since the times of the eff behind the reexamination.
But Codes, you neglect the hype factor. Neom has always run on latent potential, IMOThis trumps the patent confirm. Not the nosebleed from .025-0.21, but still a nice welcome trajectory.